Nebacumab

Nebacumab is a human monoclonal antibody developed for the treatment of sepsis.^[1] It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.^[2]

Nebacumab

Monoclonal antibody
Type	Whole antibody
Source	Human
Target	endotoxin
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J06BC01 (WHO)
Identifiers
CAS Number	138661-01-5 N
ChemSpider	none
UNII	908FWN27WK
KEGG	D05126 Y
NY (what is this?)  (verify)